Cambridge startup Arteaus has $18M to develop migraine drug
Page 1 of 1
Cambridge startup Arteaus has $18M to develop migraine drug
Boston Business Journal by Michelle Lang, Masshightech.com
Date: Wednesday, October 19, 2011, 11:58am EDT
Cambridge startup Arteaus has $18 million in venture capital financing to develop a drug for migraines, starting with technology licensed from Eli Lilly and Co. (NYSE: LLY)
Aiming to prevent migraines, Cambridge biotech Arteaus Therapeutics LLC has attracted $18 million in funding from Atlas Venture and OrbiMed Advisors. As part of the financing, OrbiMed entrepreneur-in-residence Thomas Schuetz will join Atlas Venture partner Jean-Francois Formela on the board of directors.
The previously stealthy company, which does not yet have a website, announced its funding today in a news release in which it shed light on its antibody-based technology. Arteaus has licensed worldwide development rights from Eli Lilly and Co. (NYSE: LLY) to an antibody to calcitonin gene-related peptide.
Arteaus has already begun conducting a Phase 1 study, in which safety, pharmacokinetics and pharmacodynamics of the antibody will be evaluated. The company said it should have results from the trial ready for presentation next year, with a multi-dose part of the study coming later in 2011 and a Phase 2 trial in the second half of 2012.
http://www.bizjournals.com/boston/news/2011/10/19/arteaus-aims-for-migraine-treatment.html
Date: Wednesday, October 19, 2011, 11:58am EDT
Cambridge startup Arteaus has $18 million in venture capital financing to develop a drug for migraines, starting with technology licensed from Eli Lilly and Co. (NYSE: LLY)
Aiming to prevent migraines, Cambridge biotech Arteaus Therapeutics LLC has attracted $18 million in funding from Atlas Venture and OrbiMed Advisors. As part of the financing, OrbiMed entrepreneur-in-residence Thomas Schuetz will join Atlas Venture partner Jean-Francois Formela on the board of directors.
The previously stealthy company, which does not yet have a website, announced its funding today in a news release in which it shed light on its antibody-based technology. Arteaus has licensed worldwide development rights from Eli Lilly and Co. (NYSE: LLY) to an antibody to calcitonin gene-related peptide.
Arteaus has already begun conducting a Phase 1 study, in which safety, pharmacokinetics and pharmacodynamics of the antibody will be evaluated. The company said it should have results from the trial ready for presentation next year, with a multi-dose part of the study coming later in 2011 and a Phase 2 trial in the second half of 2012.
http://www.bizjournals.com/boston/news/2011/10/19/arteaus-aims-for-migraine-treatment.html
Similar topics
» Migraine organisations hope NICE review of BOTOX will end misery of chronic migraine
» Migraine Actions -Challenging Migraine October 2011 newsletter is now available online
» National Migraine Centre (formerly the City of London Migraine Clinic) gets new brand
» Migraine Action - Managing migraine through physical therapy - Please complete our survey
» New Paper - Written by the City of London Migraine Clinic - Progress in the Pharmacotherapy of Menstrual Migraine
» Migraine Actions -Challenging Migraine October 2011 newsletter is now available online
» National Migraine Centre (formerly the City of London Migraine Clinic) gets new brand
» Migraine Action - Managing migraine through physical therapy - Please complete our survey
» New Paper - Written by the City of London Migraine Clinic - Progress in the Pharmacotherapy of Menstrual Migraine
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Thu Mar 30, 2017 9:04 am by Sarah
» Facebook group - now set up
Fri Feb 24, 2017 7:43 am by Tee
» cluster headache
Wed Feb 15, 2017 3:51 pm by Heregailing
» Your view on migraines and social media
Fri Feb 10, 2017 4:17 am by Tee
» Fats and Chronic Pain/Headaches
Thu May 19, 2016 10:52 pm by Sarah
» National hospital - London
Sun Jan 10, 2016 3:18 pm by pīwakawaka
» Just saying Hello
Sun Jan 10, 2016 3:12 pm by pīwakawaka
» Botox for harmeplegic migraines
Thu Sep 24, 2015 10:59 pm by Robyn17
» Hello and thank you
Mon May 25, 2015 12:55 am by ajdesq